Office of Medical Marijuana Use Enforcement: Curaleaf
https://www.floridahealth.gov/newsroom/2021/11/20211108-ommu-curaleaf.pr.html
WebOn November 2, 2021, the Florida Department of Health’s Office of Medical Marijuana Use (OMMU), determined that Curaleaf Florida, LLC d/b/a Curaleaf (Curaleaf) dispensed medical marijuana products to qualified patients that reported a failed testing value of Aspergillus in violation of Rule 64ER20-9 (2) (a)3., Florida Administrative Code.
DA: 7 PA: 20 MOZ Rank: 69